
The Baseline Problem
Most biomarkers fluctuate naturally within a person, so one annual value often reflects the time of day, fasting status, stress, and recent activity more than your long-term set point. Studies that measured lipids and apolipoproteins monthly for a year found that one or two measurements can genuinely misrepresent someone's baseline. Monthly sampling dilutes the outliers and lets you estimate a stable personal baseline. Your normal, not the population's.
The Trend Problem
Physiologic change unfolds on a 4-to-12-week timescale: lipids and ApoB respond to diet, exercise, and weight loss in as little as 4–8 weeks; CRP can improve within weeks of better sleep or lower stress; TSH shifts over 4–8 weeks during dose titration or weight change; sex hormones move with training load, calories, and on TRT or HRT dosing schedules. Monthly testing gives you the slope: stable, improving, plateauing, or drifting somewhere unexpected.
The AI Multiplier
AI models run on repeated observations. With annual data they can describe values; with monthly data they can distinguish fluctuation from trend, quantify your personal biological variability, catch subtle directional changes early, and tune recommendations to your physiology rather than population averages.
Traditional intervals were built for diagnosis and medication safety, not high-resolution personal tracking. Monthly testing simply aligns measurement with the speed your biology actually changes complementing your medical care with context it was never designed to capture.
